Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
Condition(s):InfluenzaLast Updated:January 25, 2012Completed
Hide Studies Not Open or Pending
Condition(s):InfluenzaLast Updated:January 25, 2012Completed
Condition(s):HPV Vaccine; HPV Infection; HIV-1-infectionLast Updated:January 15, 2021Completed
Condition(s):CytomegalovirusLast Updated:May 19, 2015Completed
Condition(s):Measles Antibody Seroconversion; Rubella Antibody Seroconversion; Rotavirus Geometric Mean Titer (GMT); Rotavirus Immunoglobulin A (IgA) SeropositivityLast Updated:March 13, 2019Completed
Condition(s):Pneumococcal VaccineLast Updated:May 30, 2023Completed
Condition(s):Aging; Influenza Vaccine; Dendritic Cell; Vaccine ResponseLast Updated:September 16, 2022Recruiting
Condition(s):Hepatitis E InfectionLast Updated:October 8, 2020Completed
Condition(s):Diphtheria; Tetanus; Pertussis; PoliomyelitisLast Updated:June 28, 2023Completed
Condition(s):Vaccine Response ImpairedLast Updated:December 29, 2015Completed
Condition(s):Meningitis; Meningococcal Meningitis; Meningococcal InfectionsLast Updated:April 4, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.